These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 11709799)

  • 1. Experimental model of yellow fever in the golden hamster (Mesocricetus auratus).
    Arya SC
    J Infect Dis; 2001 Dec; 184(11):1496-7. PubMed ID: 11709799
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental yellow fever virus infection in the Golden hamster (Mesocricetus auratus). II. Pathology.
    Xiao SY; Zhang H; Guzman H; Tesh RB
    J Infect Dis; 2001 May; 183(10):1437-44. PubMed ID: 11319680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental yellow fever virus infection in the Golden Hamster (Mesocricetus auratus). I. Virologic, biochemical, and immunologic studies.
    Tesh RB; Guzman H; da Rosa AP; Vasconcelos PF; Dias LB; Bunnell JE; Zhang H; Xiao SY
    J Infect Dis; 2001 May; 183(10):1431-6. PubMed ID: 11319679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yellow fever virus isolated from a fatal post vaccination event: an experimental comparative study with the 17DD vaccine strain in the Syrian hamster (Mesocricetus auratus).
    Rodrigues SG; da Rosa AP; Galler R; Barros VL; Vieira Cde M; da Rosa JF; Azevedo Rdo S; Nunes MR; da Rosa ES; Vasconcelos PF
    Rev Soc Bras Med Trop; 2004; 37 Suppl 2():69-74. PubMed ID: 15586900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of clinical outcome and histopathology of yellow fever virus infection in a hamster model by previous infection with heterologous flaviviruses.
    Xiao SY; Guzman H; da Rosa AP; Zhu HB; Tesh RB
    Am J Trop Med Hyg; 2003 Jun; 68(6):695-703. PubMed ID: 12887029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic and molecular characterization of a non-lethal, hamster-viscerotropic strain of yellow fever virus.
    McArthur MA; Xiao SY; Barrett AD
    Virus Res; 2005 Jun; 110(1-2):65-71. PubMed ID: 15845256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental yellow fever virus infection in the golden hamster (Mesocricetus auratus) III. Clinical laboratory values.
    Sbrana E; Xiao SY; Popov VL; Newman PC; Tesh RB
    Am J Trop Med Hyg; 2006 Jun; 74(6):1084-9. PubMed ID: 16760525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place?
    Barrett AD; Teuwen DE
    Curr Opin Immunol; 2009 Jun; 21(3):308-13. PubMed ID: 19520559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yellow fever vaccination of human immunodeficiency virus-infected patients: report of 2 cases.
    Receveur MC; Thiébaut R; Vedy S; Malvy D; Mercié P; Bras ML
    Clin Infect Dis; 2000 Sep; 31(3):E7-8. PubMed ID: 11017859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a viscerotropic yellow fever vaccine variant from a patient in Brazil.
    Engel AR; Vasconcelos PF; McArthur MA; Barrett AD
    Vaccine; 2006 Apr; 24(15):2803-9. PubMed ID: 16464518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yellow fever: epidemiology and prevention.
    Barnett ED
    Clin Infect Dis; 2007 Mar; 44(6):850-6. PubMed ID: 17304460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yellow fever vaccine.
    Monath TP
    Expert Rev Vaccines; 2005 Aug; 4(4):553-74. PubMed ID: 16117712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Yellow fever].
    Wiercińska-Drapało A
    Przegl Epidemiol; 2004; 58 Suppl 1():101-5. PubMed ID: 15807166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yellow fever vaccines and international travelers.
    Barnett ED; Wilder-Smith A; Wilson ME
    Expert Rev Vaccines; 2008 Jul; 7(5):579-87. PubMed ID: 18564013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yellow fever vaccine safety: a reality or a myth?
    Arya SC
    Vaccine; 2002 Nov; 20(31-32):3627-8. PubMed ID: 12399186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213/77 yellow fever vaccines in children: implications for the Brazilian National Immunization Program.
    Collaborative Group for Studies with Yellow Fever Vaccine
    Vaccine; 2007 Apr; 25(16):3118-23. PubMed ID: 17316925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yellow fever vaccine. WHO position paper.
    World Health Organization
    Wkly Epidemiol Rec; 2003 Oct; 78(40):349-59. PubMed ID: 14569711
    [No Abstract]   [Full Text] [Related]  

  • 18. Vaccines and vaccination against yellow fever. WHO position paper -- June 2013.
    Wkly Epidemiol Rec; 2013 Jul; 88(27):269-83. PubMed ID: 23909008
    [No Abstract]   [Full Text] [Related]  

  • 19. Yellow fever vaccine-associated viscerotropic disease and death in Spain.
    Doblas A; Domingo C; Bae HG; Bohórquez CL; de Ory F; Niedrig M; Mora D; Carrasco FJ; Tenorio A
    J Clin Virol; 2006 Jun; 36(2):156-8. PubMed ID: 16597510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yellow fever 17-D vaccine is neurotropic and produces encephalitis in immunosuppressed hamsters.
    Mateo RI; Xiao SY; Travassos da Rosa AP; Lei H; Guzman H; Lu L; Tesh RB
    Am J Trop Med Hyg; 2007 Nov; 77(5):919-24. PubMed ID: 17984354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.